| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3413413 | Médecine et Maladies Infectieuses | 2010 | 4 Pages |
Abstract
Prevenar® vaccine coverage evolved well since its universal recommendation achieving a 89.51Â % rate for the first dose. The chase of a brought closer follow-up seems important to assess the impact of this new vaccine strategy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
D. Helou, M. Moukagni-Pelzer, V. Hoeusler-Vassant, H. Huvenne, R. El-Kohen, J. Raymond, N. Kalach,